RVBA-PFIZE▲Listed

Pfizer

Pharma Manufacturing·Drug Manufacturers - General

PFE (NYSE)·NEW YORK·US

Verified credentials

SBTi Validated1.5°CCDP Listed

Company website

Website

Pfizer: One of the world's premier biopharmaceutical companies

Breakthroughs that change patients’ lives.

pfizer.com ↗

Decarbonisation trajectory · all scopes

Scope 1 + 2· base 2019 · 1.2M tCO2eScope 3· base 2019 · 4.3M tCO2e

Headline intensities

Reporting year 2024·Values in USD ($)

Peer cohort: Pharma Manufacturing · lower is better

Revenue intensity

Carbon / $m revenue

72.8tCO2e / $m

Carbon per million dollars of revenue. The legacy industry-standard reference (CDP, MSCI). Useful for cross-sector context, but distorted by margin — high-margin firms appear artificially efficient. Read alongside the operational and asset intensities for the full picture.

Top quartile

better than 75% of peers

best 72.8n=2 peersworst 105

Operational intensity

Carbon / $m OpEx

98.3tCO2e / $m

OpEx (operating expenditure) is the running cost of the business — staff, services, energy, materials. This shows how carbon-intensive operations are per million dollars of spend. Removes the margin distortion that revenue-based ratios introduce.

Top quartile

better than 75% of peers

best 98.3n=2 peersworst 154

Economic intensity

Carbon / $m EVIC

21.5tCO2e / $m

EVIC (Enterprise Value Including Cash) is the firm's total capital footprint — equity + debt + cash + minority interest. The EU's standard intensity measure (SFDR PAI 3) — answers: how much carbon does each million of capital deployed in this business produce?

Top quartile

better than 75% of peers

best 21.5n=2 peersworst 22.4

Asset intensity

Carbon / $m PP&E + leased

252tCO2e / $m

PP&E (Property, Plant & Equipment) plus leased real-estate assets is the firm's physical infrastructure on the balance sheet. This shows the carbon intensity of that physical footprint — uses Scope 1+2+3 for consistency with the other headline intensities. Surfaces stranded-asset risk for asset-heavy firms.

Top quartile

better than 75% of peers

best 252n=2 peersworst 284

Climate action evidence

1 record · 1 source

Carbon credits retired

No retirement evidence on file (third-party or self-reported).

Renewable electricity

14 %

Self-reported renewable electricity share, FY2024

RE100 member

Joined 2022 · target 2030

Sources

· RE100

Registry retirements are direct evidence; commitments are forward-looking pledges. EPA snapshot covers FY2019–FY2020.

Targets

Near-term

4 targets

Scope	Base	Target	Reduction	Alignment	Progress	Status
Scope 1 + 2Absolute	2019	2030	−46%	1.5°C	−6.9% reductionof −46% target · 15% there	Off track
Scope 2	2019	2030	−1%	1.5°C	insufficient data	—
Scope 3	—	2025	—	NA	absolute-value target	—
Scope 3Absolute	2019	2025	−10%		−17.4% reductionof −10% target · 174% there	On track

Long-term

2 targets

Scope	Base	Target	Reduction	Alignment	Progress	Status
Scope 1 + 2	2019	2040	63,317 tCO2e	Not validated	absolute-value target	—
Scope 3	2019	2040	311,726 tCO2e	Not validated	absolute-value target	—

Net zero

1 target

Scope	Base	Target	Reduction	Alignment	Progress	Status
Scope 1 + 2	—	2040	—	In corporate strategy	absolute-value target	—

⚠ Some targets show progress vs the earliest extracted year as a baseline approximation. The real base-year value will be used once historical reports are extracted.

Progress · absolute tCO2e

Scope 1 + 2 trajectory vs target

Scope 1 + 2 · 46% by 2030 · 1.5°C

ActualLinear1.5°C

Scope 3 trajectory vs target

Scope 3 · 10% by 2025

ActualLinear1.5°C

Latest news· last 5 of 19

full news log →

2019 base year emissions recalculated (Scope 1, 2, 3)
Base year (2019) emissions recalculated for Scope 1, Scope 2 location and market-based, and Scope 3 due to methodology changes and structural changes (Seagen acquisition, Karachi divestiture). Limited assurance obtained for updated 2019 baseline covering Scope 1, 2, and Scope 3 categories 1, 2, 4, 5, 6.
2024
VPPAs covering ~100% of NA and EU electricity coming online in 2025
VPPAs covering solar projects in Spain and the United States, coming online in 2025, are expected to generate RECs to cover approximately 100% of Pfizer's purchased electricity needs in North America and the EU.
2024
Reasonable assurance obtained for Scope 1 and Scope 2 emissions
Pfizer obtained reasonable assurance (ISAE 3000) for Scope 1 and Scope 2 (location and market-based) emissions, with limited assurance for Scope 3 categories. This represents a higher level of assurance than typical limited assurance.
2024
Sold Karachi, Pakistan manufacturing site to Lucky Core Industries
Pfizer's manufacturing site in Karachi, Pakistan was sold to Lucky Core Industries (LCI) in 2024. Also exited former NY HQ in July 2024 following lease expiry.
2024
Added well-to-wheel emissions to air travel (Scope 3 Cat 6)
Air travel emissions for 2023 were adjusted to include well-to-wheel (WTW) emissions in accordance with the GHG Protocol, resulting in an 8% increase from the previously reported value for Business Travel. This makes the inventory more complete.
2024

Latest reporting year· 6 earlier years on Data-by-year tab

all years + ratios →

2026

reporting year

Financials

Revenue—

OpEx—

FTE—

Market cap (FY-end)—

Climate

Scope 1—

Scope 2 (market)—

Scope 2 (location)—

Scope 3 total—

Source documents· FY2025· 1 earlier doc on Data-by-year tab

all documents →

cdp response2025

via jina search · 1.5 MB

extractedOPEN PDF ↗